Cloning, Expression, Purification, and Characterization of Clostridium botulinum Neurotoxin Serotype F Domains
The use of recombinant BoNT domains has been proposed as a means to develop strategies to treat and prevent botulism. Here, details on the molecular cloning, protein expression, purification, and immunoreactivity of BoNT/F domains from Clostridium botulinum are presented. Initially, full-length synt...
Main Authors: | Santosh Dulal, Bhupal Ban, Gi Hyoek Yang, Hyun Ho Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
Biotechnology Society of Nepal
2012-12-01
|
Series: | Nepal Journal of Biotechnology |
Subjects: |
Similar Items
-
Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01) -
Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D
by: Denis Y. Otaka, et al.
Published: (2017-09-01) -
Utilities of Botulinum Toxins in Dermatology and Cosmetology
by: Naik PP
Published: (2021-09-01) -
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01) -
Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
by: Jonathan R. Davies, et al.
Published: (2020-09-01)